Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 2
1991 2
1994 1
1996 2
1997 2
1998 2
1999 3
2000 6
2001 5
2002 1
2003 5
2004 10
2005 7
2006 7
2007 10
2008 8
2009 3
2010 5
2011 5
2012 7
2013 3
2014 5
2015 10
2016 5
2017 8
2018 4
2019 10
2020 12
2021 13
2022 8
2023 2
2024 11
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Chu Q, Perrone F, Greillier L, Tu W, Piccirillo MC, Grosso F, Lo Russo G, Florescu M, Mencoboni M, Morabito A, Cecere FL, Ceresoli GL, Dawe DE, Zucali PA, Pagano M, Goffin JR, Sanchez ML, Gridelli C, Zalcman G, Quantin X, Westeel V, Gargiulo P, Delfanti S, Tu D, Lee CW, Leighl N, Sederias J, Brown-Walker P, Luo Y, Lantuejoul S, Tsao MS, Scherpereel A, Bradbury P, Laurie SA, Seymour L. Chu Q, et al. Among authors: ceresoli gl. Lancet. 2023 Dec 16;402(10419):2295-2306. doi: 10.1016/S0140-6736(23)01613-6. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931632 Clinical Trial.
Sex hormones, the anticancer immune response, and therapeutic opportunities.
Conforti F, Pala L, Di Mitri D, Catania C, Cocorocchio E, Laszlo D, Ceresoli G, Locatelli M, Facella F, De Pas T, Rambaldi B, Rambaldi A, Viale G, Bagnardi V, Giaccone G, Mantovani A. Conforti F, et al. Among authors: ceresoli g. Cancer Cell. 2025 Mar 10;43(3):343-360. doi: 10.1016/j.ccell.2025.02.013. Cancer Cell. 2025. PMID: 40068594 Review.
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial.
Szlosarek PW, Creelan BC, Sarkodie T, Nolan L, Taylor P, Olevsky O, Grosso F, Cortinovis D, Chitnis M, Roy A, Gilligan D, Kindler H, Papadatos-Pastos D, Ceresoli GL, Mansfield AS, Tsao A, O'Byrne KJ, Nowak AK, Steele J, Sheaff M, Shiu CF, Kuo CL, Johnston A, Bomalaski J, Zauderer MG, Fennell DA; ATOMIC-Meso Study Group. Szlosarek PW, et al. Among authors: ceresoli gl. JAMA Oncol. 2024 Apr 1;10(4):475-483. doi: 10.1001/jamaoncol.2023.6789. JAMA Oncol. 2024. PMID: 38358753 Free PMC article. Clinical Trial.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Pinto C, Zucali PA, Pagano M, Grosso F, Pasello G, Garassino MC, Tiseo M, Soto Parra H, Grossi F, Cappuzzo F, de Marinis F, Pedrazzoli P, Bonomi M, Gianoncelli L, Perrino M, Santoro A, Zanelli F, Bonelli C, Maconi A, Frega S, Gervasi E, Boni L, Ceresoli GL. Pinto C, et al. Among authors: ceresoli gl. Lancet Oncol. 2021 Oct;22(10):1438-1447. doi: 10.1016/S1470-2045(21)00404-6. Epub 2021 Sep 6. Lancet Oncol. 2021. PMID: 34499874 Clinical Trial.
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates.
Pala L, Merlo F, Sala I, Pagan E, Oriecuia C, Specchia C, Catania C, Cocorocchio E, Laszlo D, Ceresoli G, Locatelli M, De Pas T, Zambelli A, Cortes J, Giaccone G, Moore KN, Bardia A, Viale G, Gelber RD, Bagnardi V, Conforti F. Pala L, et al. Among authors: ceresoli g. J Natl Cancer Inst. 2025 Aug 1;117(8):1557-1564. doi: 10.1093/jnci/djaf049. J Natl Cancer Inst. 2025. PMID: 40036179
Malignant pleural mesothelioma.
Ceresoli GL, Betta GP, Castagneto B, Facciolo F, Arcangeli G, Zucali PA, Libener R, De Giovanni D, Melis E, Mirri MA. Ceresoli GL, et al. Ann Oncol. 2006 Mar;17 Suppl 2:ii13-16. doi: 10.1093/annonc/mdj912. Ann Oncol. 2006. PMID: 16608972 Free article. Review. No abstract available.
Clinical staging of malignant pleural mesothelioma: current perspectives.
Bonomi M, De Filippis C, Lopci E, Gianoncelli L, Rizzardi G, Cerchiaro E, Bortolotti L, Zanello A, Ceresoli GL. Bonomi M, et al. Among authors: ceresoli gl. Lung Cancer (Auckl). 2017 Aug 18;8:127-139. doi: 10.2147/LCTT.S102113. eCollection 2017. Lung Cancer (Auckl). 2017. PMID: 28860886 Free PMC article. Review.
175 results